Specialty plasma programs: the highest pay per donation — if you qualify
What makes plasma "specialty"?
Manufacturers of diagnostics and certain therapies need plasma with specific, hard-to-find characteristics — anti-D antibodies, high post-vaccination titers (tetanus, rabies, COVID boosters), autoimmune conditions, or rare blood factors. Because few donors qualify, the pay per donation is several times the general rate. Some programs even pay travel costs to bring qualified donors to a collection site.
Programs that publish their rates
These organizations publish specialty compensation — amounts and terms from their own sites; always confirm current details directly:
| Program | Published pay | Where | Shape |
|---|---|---|---|
| PlasmaLab International | $185 per donation (qualified specialty donors) | Everett, WA | Physical collection center |
| Plasma Services Group | $200+ per donation, travel paid for qualified donors | Huntingdon Valley, PA (recruits nationwide) | Collection center + travel program |
| BioLynk | Up to $500 per donation; qualifying travel may be prepaid | Nationwide via partner centers | Recruiter — routes you to a partner facility |
| Access Clinical | Cash compensation, varies by facility | US partner collection facilities | Recruiter — routes you to a partner facility |
| Research Blood Components | Fixed cash stipend per procedure | Watertown, MA | Research blood/plasma components |
"Recruiter" programs aren't donation centers themselves — they screen you and route you to partner facilities, which is why they can cover travel. Regular centers also run smaller specialty programs: several chains we track note programs for anti-D, tetanus, rabies, and varicella-zoster antibodies at specific locations — ask your local center what it collects.
Disease-state programs that don't publish rates
These programs confirm they compensate qualifying disease-state donors but don't publish amounts — if you have a diagnosed autoimmune or infectious condition, they're worth a direct inquiry:
| Program | Focus | What they say about pay |
|---|---|---|
| RMA Plasma | Disease-state recruitment — autoimmune conditions, infectious diseases, unusual immunological markers | "Donors are compensated for their time… Compensation rates vary depending on the disease state." Partner centers set amounts and locations. |
| ImmunoVision | Autoimmune disease-state plasma donor program (Springdale, AR area) | Active collection program; compensation not published — contact to ask. |
| Sanguine Biosciences | Research biospecimen network — disease-state plasma from research-consented participants | Compensation and collection locations vary by study; confirm directly before participating. |
| Southern Blood Services | Antibody programs — Rho(D)/Rh incompatibility, red cell antibody, rabies antibody, hepatitis B antibody. Fixed centers in Birmingham and Tuscaloosa, AL and Nashville, TN | "You will earn compensation for each donation" — no dollar figure published anywhere on their site. Call the center for current rates. |
| HRF, Inc. | Rare coagulation plasma — donors with a diagnosed bleeding or clotting disorder. Raleigh, NC | Describes "a generous compensation plan" with no amount published. Requires an application and screening packet rather than walk-in donation. |
Southern Blood Services and HRF run fixed collection centers, but we don't list them in the main directory because neither publishes a rate and neither takes general walk-in donors — the eligibility gate is a specific antibody or diagnosis, so a city listing would imply an offer that may not apply to you.
Conditions these programs commonly seek include lupus, rheumatoid arthritis, celiac disease, Sjögren's, thyroid disease, CMV, Lyme disease, and hepatitis — eligibility always requires a confirmed diagnosis and screening.
What the FDA actually recognizes
Specialty collection isn't a marketing invention. FDA's Guide to Inspections of Source Plasma Establishments describes two separate categories of specialty collection, and a center must have CBER approval before running either one. Which category you'd fall into changes what to expect — including whether you can still donate normally afterward.
1. "Disease state" collection
For donors living with or recovering from a condition. FDA's guide notes these donors "may not meet all Source Plasma donor suitability criteria, but they have recovered or are recovering from an illness and are in good health," and that for some conditions a physician may authorize collection. FDA's partial list of approved disease-state collections, with the conditions each marker is commonly associated with:
| FDA-listed collection | Commonly associated with |
|---|---|
| Anti-nuclear antibody (ANA) | Lupus and other autoimmune connective-tissue disease |
| Anti-DNA antibody | Lupus (anti-dsDNA) |
| Anti-thyroglobulin antibody | Autoimmune thyroid disease (Hashimoto's, Graves') |
| Anti-microsomal antibody | Autoimmune thyroid disease (now usually called anti-TPO) |
| Anti-smooth muscle antibody | Autoimmune hepatitis |
| Anti-mitochondrial antibody | Primary biliary cholangitis |
| Elevated IgE | Severe allergy and atopic conditions |
| Antistreptolysin-O | Recent or past streptococcal infection |
| Heterophile antibody | Infectious mononucleosis (Epstein-Barr) |
| Lyme disease | Lyme disease exposure |
| Syphilis | Syphilis exposure |
| Hemophilia (or other coagulation factor deficient plasma) | Hemophilia and clotting factor deficiencies |
| Anti-HIV antibody | HIV — collected only under a separate restricted program (see below) |
These are antibody and marker categories, not diagnoses. Screening tests for the marker — so having a diagnosis doesn't guarantee you qualify, and the association column is general medical context, not a claim about your eligibility.
2. "Disease associated" antibodies
A different and generally easier category: antibodies you carry from a past exposure or a vaccination. Here FDA says donors "should meet all required and recommended Source Plasma donor suitability criteria" — meaning you're an ordinary donor who happens to have something extra. Importantly, FDA also states that discovering one of these antibodies does not prevent you from returning to normal Source Plasma collection if the antibody is no longer wanted. The listed antibodies:
The hepatitis distinction that matters
"Paid hepatitis plasma donation" is ambiguous in a way that matters a lot. The FDA list names anti-HAV and anti-HBs — hepatitis antibodies, which generally mean immunity from vaccination or past recovery. Those donors meet normal suitability criteria. That is the opposite of an active hepatitis infection: donors who test positive for viral markers like HBsAg fall under a separate, tightly restricted "high risk" program requiring its own CBER approval, where collections are directed to research, in-vitro tests, or therapeutic development — and a reactive screening test means deferral from regular donation. If you're immune, you may be valuable to a program. If you have an active infection, you are not eligible for paid donation.
Who typically qualifies
- Rare antibodies — e.g. anti-D (often Rh-negative donors previously exposed), anti-tetanus, anti-rabies, anti-HBs after vaccination.
- Recent vaccination or booster — high antibody titers are valuable for a window of time.
- Diagnosed conditions — some autoimmune and other conditions make plasma valuable for test manufacturing.
- Unusual blood types — including rare type combinations.
Screening (a blood test) determines eligibility — you can't self-certify into the high rate, and programs pay standard or nothing if you don't qualify.
What the FDA lists don't tell you
- Nothing about pay. These documents govern what collectors may do with CBER approval. They set no compensation, and FDA's inspection guide states plainly that it "does not bind FDA, and does not confer any rights, privileges, benefits, or immunities."
- Nothing about availability near you. CBER approves disease-state collection per establishment, via a license supplement. A condition appearing on the list doesn't mean any center in your state collects it.
- Some advertised conditions aren't on either list. Recruiters commonly mention celiac disease, rheumatoid arthritis, and Sjögren's; none are named in the FDA lists above. That doesn't make them fake — they may be collected under a broader approval or for research rather than as Source Plasma — but we can't source them to FDA, so we don't claim it.
Sources: FDA, Guide to Inspections of Source Plasma Establishments, Section 3 (June 1997, editorial revisions April 2001) · FDA, Implementing a Collection Program for Source Plasma Containing Disease-Associated and Other Immunoglobulin (IgG) Antibodies (2006). Checked 2026-08-01.
Honest caveats
- These programs serve a tiny share of donors; for most people, a high-paying general center is the realistic option.
- Rates and program availability change; verify on the program's site before traveling anywhere.
- We list these as published information, not endorsements — we have no relationship with any of them.
Not specialty-eligible? Compare general centers
New-donor first-month offers at general centers reach $825. Browse by state: